noha Tawfik

Dr. noha Tawfik


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2021 in Journal of Cosmetic Dermatology
Verified
Journal Article
Closed access
PDF file
AEAmira A.M. Emam
Amira A.M. Emam
HNHesham A. Nada
Hesham A. Nada
MAMona A. Atwa
Mona A. Atwa
NTnoha Tawfik
noha Tawfik

3 September 2022 in Dermatologic Therapy
Verified
Journal Article
Closed access
NTnoha Tawfik
noha Tawfik
MEMoustafa M. K. Eyada
Moustafa M. K. Eyada
RHReem E. Abdel El Hamid
Reem E. Abdel El Hamid
HHHalim Maher Halim
Halim Maher Halim
The Genital warts are common sexually transmitted diseases caused by definite types of human papillomavirus. There are many strategies for the treatment of genital wart and intralesional immunotherapy is considered to be a safe and effective treatment modality. However, there are lack of studies that comparing the clinical effectiveness of intralesional purified protein derivative (PPD) and Candida antigen (CA) in genital wart treatment. To investigate the effectiveness and safety of PPD and CA in the treatment of genital warts. Eighty patients were enrolled in this study and were randomly divided into 2 groups with 40 patients in each. Each antigen was injected intralesionally at a dose of 0.1 ml into the largest wart every 2 weeks until complete improvement or for a maximum of four sessions. Complete clinical response was demonstrated in 65%, 62.5% in PPD and CA groups, respectively. There was no statistically difference between both groups. After the 3-month follow-up period, 72.5%, 85% of patients showed complete clearance in PPD and CA groups respectively. Side effects were mild and insignificant in both groups. Recurrence was observed in only one patient in each group. Immunotherapy by intralesional PPD and CA injection is considered to be effective and well-tolerated modalities in treatment of genital wart with minimal side effects and recurrence rate compared to other modalities.

20 April 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
NTnoha Tawfik
noha Tawfik
HIHoda Ibrahim
Hoda Ibrahim
RHRanya Moustafa Hassan
Ranya Moustafa Hassan
AHAlaa Hosny
Alaa Hosny
DGDina E. Ghanem
Dina E. Ghanem
MAMona A. Atwa
Mona A. Atwa
(1) Background: The psoriasis susceptibility 1 (PSORS1) locus, located within the major histocompatibility complex, is one of the main genetic determinants for psoriasis, the genotyping profile for three single-nucleotide polymorphisms (SNPs) comprising the PSORS1 locus: rs1062470 within PSORS1C1/CDSN genes, rs887466 within PSORS1C3 gene, rs10484554 within LOC105375015 gene, were investigated and correlated with psoriasis risk and severity. (2) Methods: This pilot case-controlled study involved 100 psoriatic patients and 100 healthy individuals. We investigated three SNPs and assessed the relative gene expression profile for the PSORS1C1 gene. We then correlated the results with both disease risk and severity. (3) Results: The most significantly associated SNP in PSORS1 locus with psoriasis was rs10484554 with its C/T genotype 5.63 times more likely to develop psoriasis under codominant comparison. Furthermore, C/T and T/T genotypes were 5 times more likely to develop psoriasis. The T allele was 3 times more likely to develop psoriasis under allelic comparison. The relative gene expression of PSORS1C1 for psoriatic patients showed to be under-expressed compared to normal controls. (4) Conclusions: Our study revealed the association of the three studied SNPs with psoriasis risk and severity in an Egyptian cohort, indicating that rs10484554 could be the major key player in the PSORS1 locus.

1 October 2020 in Suez Canal University Medical Journal
Verified
Journal Article
Closed access
NTnoha Tawfik
noha Tawfik
HHHadeer Hussein
Hadeer Hussein
RHRanya M Hassan
Ranya M Hassan
MAMona Atwa
Mona Atwa
Background: Viral warts are benign growths that result from an infection of epidermal or mucosal cells with the human papillomavirus. Epidemiological studies have demonstrated a link between vitamin D deficiency and increased rates of infectious diseases and their resistance to treatment. Such a link between vitamin D level and wart recalcitrance is yet to be revealed. To the best of our knowledge, there were no previous studies conducted to reveal the possible relationship between vitamin D and recalcitrant warts. Aim: To assess serum vitamin D levels in patients with recalcitrant palmoplantar warts. Subjects and Methods:A cross-sectional study conducted on two groups. The first group included 35 patients with recalcitrant palmoplantar warts, the second group included 35 healthy volunteers matched for age, sex. Serum vitamin D level was measured. Results: A total of 78 participants were enrolled in this study, including 30 males and 48 females, distributed among the 3 groups. There was no statistically significant difference in serum vitamin D levels between the studied groups. Its mean level in the recalcitrant group was 26.03 ng/ml, while in the responsive group it was 29.36 ng/ml and reached 25.15ng/ml in the control group. Conclusion: low serum vitamin D levels do not seem to increase the susceptibility of warts to get resistant to treatment.

21 November 2021 in Journal of Cosmetic Dermatology
Verified
Journal Article
Closed access
PDF file
NTnoha Tawfik
noha Tawfik
MAMohamed T. Anbar
Mohamed T. Anbar
MAMona A. Atwa
Mona A. Atwa

1 December 2022 in Suez Canal University Medical Journal
Verified
Journal Article
Closed access
NTnoha Tawfik
noha Tawfik
SRSamar Ga Romeia
Samar Ga Romeia
NYNahed Youssef
Nahed Youssef
MAMona A. Atwa
Mona A. Atwa
Background: Psoriasis is a chronic multifactorial inflammatory autoimmune disease. It has significant impacts on health and quality of life. Platelets play a major role in the pathogenesis of psoriasis, and the activated platelets increase the migration of leukocytes to the skin, increasing the release of inflammatory cytokines. Recent studies showed that MPV (mean platelet volume) could be used as an indicator of platelet function and activation. Previous studies assessed only the value of MPV in psoriatic patients without studying its relationrelationship < /ins> with different treatment modalities. Aim:To study the changes in MPV in psoriasis patients and its association with disease severity after treatment with NB-UVB. Patents and Methods: 25 psoriatic patients were assessed for MPV and psoriasis area and severity index score (PASI) before treatment, during treatment and after treatment with NBUVB (three times weekly for 3 months). Results:The relation between MPV and PASI was statistically insignificant before and after treatment. The PASI score was significantly decreases after treatment. Conclusion: This study demonstrated insignificant correlation between MPV levels and PASI score of psoriatic patients before and after NBUVB phototherapy. Further studies on larger number of patients were needed to assess the relation between MPV and psoriasis.